In the past week, SAVA stock has gone up by 1.78%, with a monthly decline of -12.96% and a quarterly plunge of -9.54%. The volatility ratio for the week is 8.29%, and the volatility levels for the last 30 days are 6.09% for Cassava Sciences Inc The simple moving average for the past 20 days is -3.13% for SAVA’s stock, with a 12.90% simple moving average for the past 200 days.
Is It Worth Investing in Cassava Sciences Inc (NASDAQ: SAVA) Right Now?
Company’s 36-month beta value is -0.62.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 2 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for SAVA is 41.77M, and currently, short sellers hold a 44.46% ratio of that floaft. The average trading volume of SAVA on November 14, 2024 was 1.68M shares.
SAVA) stock’s latest price update
Cassava Sciences Inc (NASDAQ: SAVA)’s stock price has soared by 2.42 in relation to previous closing price of 25.18. Nevertheless, the company has seen a gain of 1.78% in its stock price over the last five trading days. zacks.com reported 2024-11-12 that Cassava Sciences (SAVA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Analysts’ Opinion of SAVA
Many brokerage firms have already submitted their reports for SAVA stocks, with H.C. Wainwright repeating the rating for SAVA by listing it as a “Buy.” The predicted price for SAVA in the upcoming period, according to H.C. Wainwright is $116 based on the research report published on October 08, 2024 of the current year 2024.
B. Riley Securities gave a rating of “Neutral” to SAVA, setting the target price at $44 in the report published on November 16th of the previous year.
SAVA Trading at -6.18% from the 50-Day Moving Average
After a stumble in the market that brought SAVA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -38.89% of loss for the given period.
Volatility was left at 6.09%, however, over the last 30 days, the volatility rate increased by 8.29%, as shares sank -12.93% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -12.56% lower at present.
During the last 5 trading sessions, SAVA rose by +1.62%, which changed the moving average for the period of 200-days by +7.52% in comparison to the 20-day moving average, which settled at $26.62. In addition, Cassava Sciences Inc saw 14.57% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for SAVA
Current profitability levels for the company are sitting at:
- -46.82 for the present operating margin
- 0.59 for the gross margin
The net margin for Cassava Sciences Inc stands at -7.52. The total capital return value is set at -0.66. Equity return is now at value -10.98, with -8.91 for asset returns.
Currently, EBITDA for the company is -95.69 million with net debt to EBITDA at 1.14. When we switch over and look at the enterprise to sales, we see a ratio of 478.31. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.55.
Conclusion
In a nutshell, Cassava Sciences Inc (SAVA) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
